跳至主要内容
临床试验/JPRN-UMIN000003503
JPRN-UMIN000003503已完成未知

An open label, randomized control study for the comparison of effectiveness between Alfa-Glucosidase inhibitor and Dipeptidyl peptidase-4 (DPP-4) inhibitor in people with type 2 diabetes treated diet therapy and/or single oral hypoglycemic agent - An open label, randomized control study for the comparison of effectiveness between Alfa-Glucosidase inhibitor and Dipeptidyl peptidase-4 (DPP-4) inhibitor in people with type 2 diabetes treated diet therapy and/or single oral hypoglycemic agent

Department of Disease Control and Homeostasis, Kanazawa University Graduate School of Medical Science0 个研究点目标入组 260 人开始时间: 2010年4月21日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
260

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.None Type 2 diabetes 2.Medical history and/or complication of diabetic ketoacidosis 3.Medical history and/or complication of severe hypoglycemia 4.Insulin treatment within 16 weeks prior to the study 5.Treatment with Alfa-glucosidase inhibitors or sitagliptin within 12 weeks prior to the study 6.Treatment with glucocorticoid 7.Unstable glycemic contol 8.Hypersensitivity to or contraindication of sitagliptin and voglibose 9.AST or ALT >=2.5 time of institutional upper normal limit 10.Uncontrolled hypertension(systolic blood pressure >160mmHg or diastolic blood pressure >100mmHg) 11.Severe health problems not suitable for the study 12.Pregnant or lactating women

研究者

发起方
Department of Disease Control and Homeostasis, Kanazawa University Graduate School of Medical Science

相似试验

An open label, randomized control study for the... | 临床试验